Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2013
15th World Conference on Lung Cancer
Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.
Presentation Date(s):- October 27 - 30, 2013
- Total Presentations: 2517
-
+
P1.06 - Poster Session 1 - Prognostic and Predictive Biomarkers
- Type: Poster Session
- Track: Biology
- Presentations: 59
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.06-059 - Comparison of the characteristics and clinical course of patients with metastatic KRAS mutant lung cancers
09:30 - 09:30 | Author(s): G. Riely
- Abstract
Loading...
-
+
MO07 - NSCLC - Targeted Therapies II
- Type: Mini Oral Abstract Session
- Track: Medical Oncology
- Presentations: 14
- Moderators:T. John
- Coordinates: 10/28/2013, 16:15 - 17:45, Bayside Auditorium B, Level 1
-
+
MO07.03 - Crizotinib therapy for patients with advanced ROS1-rearranged non-small cell lung cancer (NSCLC)
16:25 - 16:30 | Author(s): S.I. Ou
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MTE12 - The New Adenocarcinoma Classification Explained
- Type: Meet the Expert (ticketed session)
- Track: Medical Oncology
- Presentations: 1
- Moderators:N. n/a
- Coordinates: 10/29/2013, 07:00 - 08:00, Bayside 104, Level 1
-
+
MTE12.1 - The New Adenocarcinoma Classification Explained
07:00 - 08:00 | Author(s): G. Riely
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.11 - Poster Session 2 - NSCLC Novel Therapies
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 46
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.11-025 - Erlotinib versus Radiation Therapy for Brain Metastases in Patients with EGFR-Mutant Lung Adenocarcinoma
09:30 - 09:30 | Author(s): N.K. Gerber
- Abstract
Loading... -
+
P2.11-026 - RET Fusion-Positive Advanced Lung Cancers: Response to First-Line Chemotherapy and Survival in Comparison to ROS1 and ALK Fusion-Positive and EGFR- and KRAS-Mutant Lung Cancers
09:30 - 09:30 | Author(s): A. Drilon
- Abstract
Loading...
-
+
Best of Posters - IASLC Selection - Part 1
- Type: Exhibit Showcase Session
- Track:
- Presentations: 4
- Coordinates: 10/29/2013, 09:55 - 10:25, Exhibit Hall, Ground Level
-
+
P1.11-008 - A phase II study of HSP90 inhibitor AUY922 and erlotinib (E) in patients (pts) with EGFR-mutant lung cancer and acquired resistance (AR) to EGFR tyrosine kinase inhibitors (EGFR TKIs).
09:55 - 10:00 | Author(s): H.A. Yu
- Abstract
Loading...
-
+
O16 - NSCLC - Targeted Therapies III
- Type: Oral Abstract Session
- Track: Medical Oncology
- Presentations: 8
- Moderators:H.A. Wakelee
- Coordinates: 10/29/2013, 10:30 - 12:00, Parkside Auditorium, Level 1
-
+
O16.06 - A phase 1 dose escalation study of a new ALK inhibitor, CH5424802/RO5424802, in ALK+ Non-Small Cell Lung Cancer (NSCLC) patients who have failed crizotinib (AF-002JG/NP28761, NCT01588028).
11:25 - 11:35 | Author(s): S. Gadgeel
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
O16.07 - Consistent therapeutic efficacy of CH5424802/RO5424802 in brain metastases among crizotinib-refractory ALK-positive non-small cell lung cancer (NSCLC) patients in an ongoing phase I/II study (AF-002JG/NP28761, NCT01588028).
11:35 - 11:45 | Author(s): S.I. Ou
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MO15 - Novel Genes and Pathways
- Type: Mini Oral Abstract Session
- Track: Biology
- Presentations: 12
- Moderators:Y. Ohe
- Coordinates: 10/29/2013, 16:15 - 17:45, Parkside Ballroom A, Level 1
-
+
MO15.07 - DISCUSSANT
16:45 - 17:00 | Author(s): G. Riely
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MO16 - Prognostic and Predictive Biomarkers IV
- Type: Mini Oral Abstract Session
- Track: Medical Oncology
- Presentations: 10
- Moderators:S. Toyooka
- Coordinates: 10/29/2013, 16:15 - 17:45, Parkside Auditorium, Level 1
-
+
MO16.06 - Clinical, structural and biochemical characterization of EGFR exon 20 insertion mutations in lung cancer
16:50 - 16:55 | Author(s): D.B. Costa
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
E10 - Targeting KRAS in Lung Cancer
- Type: Educational Session
- Track: Biology
- Presentations: 4
- Moderators:C.M. Lovly
- Coordinates: 10/30/2013, 14:00 - 15:30, Parkside Auditorium, Level 1
-
+
E10.3 - Targeting KRAS and KRAS Signaling in the Clinic
14:55 - 15:20 | Author(s): G. Riely
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
